Literature DB >> 23065047

Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.

Myoung Hee Park1, Kyu-Dong Kang, Jungil Moon.   

Abstract

PURPOSE: To investigate the common side effects of topical antiglaucoma medication, factors affecting compliance, and the utilization of herbal medicine for glaucoma treatment in South Korea. PATIENTS AND METHODS: A cross-sectional multicenter hospital-based study. In-depth interviews using a structured questionnaire were conducted with 581 individuals diagnosed with glaucoma. Additional eligibility requirements were: all participants were diagnosed with glaucoma in one or both eyes and prescribed eye drops at least one month before the start of the study, and were in a suitable condition for an interview. The frequency of response for each category in the interview questionnaire was analyzed.
RESULTS: Conjunctival injection, a stinging sensation, and blurred vision were the most frequently reported side effects, among which blurred vision was the most unbearable. Patient knowledge of glaucoma was the only factor associated with the patient's self-evaluation of compliance. Forgetfulness was the most common reason for nonadherence. Only 2.9 % of patients were taking herbal medicine.
CONCLUSIONS: Physicians should address a patient's complaint of blurred vision resulting from medication. Complete initial explanation of the consequences of nonadherence and of the potential vision loss from glaucoma are critical elements in improving patient adherence in Asian populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065047     DOI: 10.1007/s10384-012-0188-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  22 in total

1.  The compliance factor.

Authors:  E M Van Buskirk
Journal:  Am J Ophthalmol       Date:  1986-05-15       Impact factor: 5.258

2.  Visual loss in a glaucoma clinic. I. Sociological considerations.

Authors:  G L Spaeth
Journal:  Invest Ophthalmol       Date:  1970-01

3.  Compliance with treatment of patients with chronic open-angle glaucoma.

Authors:  J M MacKean; A R Elkington
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

4.  Accuracy of patient interviews and estimates by clinical staff in determining medication compliance.

Authors:  S E Norell
Journal:  Soc Sci Med E       Date:  1981-02

Review 5.  A comprehensive perspective on patient adherence to topical glaucoma therapy.

Authors:  James C Tsai
Journal:  Ophthalmology       Date:  2009-11       Impact factor: 12.079

Review 6.  Compliance with ocular therapy.

Authors:  F S Ashburn; I Goldberg; M A Kass
Journal:  Surv Ophthalmol       Date:  1980 Jan-Feb       Impact factor: 6.048

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Compliance in patients prescribed eyedrops for glaucoma.

Authors:  S C Patel; G L Spaeth
Journal:  Ophthalmic Surg       Date:  1995 May-Jun

9.  Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.

Authors:  David S Friedman; Steven R Hahn; Laurie Gelb; Jason Tan; Sonali N Shah; Elizabeth E Kim; Thom J Zimmerman; Harry A Quigley
Journal:  Ophthalmology       Date:  2008-03-05       Impact factor: 12.079

10.  Compliance barriers in glaucoma: a systematic classification.

Authors:  James C Tsai; Cori A McClure; Sarah E Ramos; David G Schlundt; James W Pichert
Journal:  J Glaucoma       Date:  2003-10       Impact factor: 2.503

View more
  13 in total

1.  Persistence with topical glaucoma therapy among newly diagnosed Japanese patients.

Authors:  Kenji Kashiwagi; Toshie Furuya
Journal:  Jpn J Ophthalmol       Date:  2013-10-25       Impact factor: 2.447

2.  Identifying outcomes that are important to patients with ocular hypertension or primary open-angle glaucoma: a qualitative interview study.

Authors:  Jimmy T Le; Kareshma Mohanty; Amanda K Bicket; Michelle E Tarver; Malvina Eydelman; Tianjing Li
Journal:  Ophthalmol Glaucoma       Date:  2019-07-31

3.  Dry eye specific quality of life in veterans using glaucoma drops.

Authors:  Andrew Camp; Sarah R Wellik; Jonathan H Tzu; William Feuer; Kristopher L Arheart; Ananth Sastry; Anat Galor
Journal:  Cont Lens Anterior Eye       Date:  2015-02-24       Impact factor: 3.077

4.  Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4.

Authors:  Etsuko Terao; Shunsuke Nakakura; Yasuko Fujisawa; Yuki Nagata; Kanae Ueda; Yui Kobayashi; Satomi Oogi; Saki Dote; Miku Shiraishi; Hitoshi Tabuchi; Tsuyoshi Yoneda; Atsuki Fukushima; Ryo Asaoka; Yoshiaki Kiuchi
Journal:  BMJ Open Ophthalmol       Date:  2020-08-02

5.  Priorities and Treatment Preferences among Surgery-Naive Patients with Moderate to Severe Open-Angle Glaucoma.

Authors:  Amanda K Bicket; Jimmy T Le; Carol Yorkgitis; Tianjing Li
Journal:  Ophthalmol Glaucoma       Date:  2020-05-16

6.  Association between glaucoma eye drops and hyperemia.

Authors:  Masahide Yanagi; Yoshiaki Kiuchi; Yuki Yuasa; Tsuyoshi Yoneda; Tamaki Sumi; Yasuhiro Hoshikawa; Masahiko Kobayashi; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2016-02-04       Impact factor: 2.447

7.  Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients.

Authors:  Makoto Aihara; Misato Adachi; Hiroshi Matsuo; Tetsuya Togano; Takeo Fukuchi; Noriyuki Sasaki
Journal:  Acta Ophthalmol       Date:  2017-04-03       Impact factor: 3.761

8.  Treatment patterns and medication adherence of patients with glaucoma in South Korea.

Authors:  Chan Yun Kim; Ki Ho Park; Jaehong Ahn; Myung-Douk Ahn; Soon Cheol Cha; Ho Soong Kim; Joon Mo Kim; Moon Jung Kim; Tae-Woo Kim; Yong Yeon Kim; Ji Woong Lee; Sang-Woo Park; Yong Ho Sohn; Kyung Rim Sung; Chungkwon Yoo; Jinhye Cha; Young-Joo Kim
Journal:  Br J Ophthalmol       Date:  2017-03-07       Impact factor: 4.638

9.  Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy.

Authors:  Yuka Hasebe; Kenji Kashiwagi; Toyoaki Tsumura; Yasuyuki Suzuki; Keiji Yoshikawa; Hirotaka Suzumura; Toshine Maeda; Ryuji Takeda; Hitomi Saito; Makoto Araie
Journal:  Patient Prefer Adherence       Date:  2018-08-27       Impact factor: 2.711

10.  The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.

Authors:  Jin A Choi; Lina D Song; Seulggie Choi; Sang Min Park; Jin Woo Kwon; Donghyun Jee
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.